Propanc Biopharma, Inc. (PPCB) stock
PPCBNasdaqPharmaceutical PreparationsFiscal year ends June 30
$1.94+0.02 (+1.09%)
Close on Nov 13, 2026Market cap $12.29MP/E –Yield –
Propanc Biopharma price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Propanc Biopharma's price to book ratio was 0.6× on Nov 11, 2026, against 19.9× a year earlier.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.6× | −11.3 |
| 2025 | Dec 31, 2025 | 12.0× | – |
See a number that looks wrong?